TRANSCRIPTION FACTOR EGR-1 ACTIVITY DOWN-REGULATES FAS AND CD23 EXPRESSION IN B-CELLS

Citation
A. Dinkel et al., TRANSCRIPTION FACTOR EGR-1 ACTIVITY DOWN-REGULATES FAS AND CD23 EXPRESSION IN B-CELLS, The Journal of immunology, 159(6), 1997, pp. 2678-2684
Citations number
51
Categorie Soggetti
Immunology
Journal title
The Journal of immunology
ISSN journal
00221767 → ACNP
Volume
159
Issue
6
Year of publication
1997
Pages
2678 - 2684
Database
ISI
SICI code
0022-1767(1997)159:6<2678:TFEADF>2.0.ZU;2-N
Abstract
Activation of mature B cells via Ag receptor cross-linking induces tra nsient expression of the transcription factor Egr-1. Although the acti vating signals leading to Egr-1 induction have been studied extensivel y, little is known about the genes that are placed further downstream within this activation cascade and that are transcriptionally regulate d by Egr-1. To identify such target genes, we established Egr-1-overex pressing transfectants from the murine B cell line K46 and from human Ramos B cells. All clones derived from K46 B cells showed increased ex pression of CD44. Most interestingly, expression of CD95 (Fas/Apo-1) a nd of CD23 was down-regulated in all K46 transfectants. As a consequen ce, they became resistant to apoptosis induced by anti-CD95 Ab treatme nt. Similarly, the Egr-1-expressing Ramos cells showed reduced levels of CD95 expression. Thus, Egr-1 seems to control the expression of dow nstream target genes not only as a transcriptional activator, but also as a repressor molecule. In B cells, Egr-1 therefore plays a critical role in integrating the short-lived signal delivered by triggering of the Ag receptor into phenotypic changes, including repression of CD95 and CD23 transcription.